WallStreetZenWallStreetZen

NASDAQ: VERA
Vera Therapeutics Inc Stock

$7.48+0.35 (+4.91%)
Updated Mar 20, 2023
VERA Price
$7.48
Fair Value Price
N/A
Market Cap
$206.88M
52 Week Low
$5.20
52 Week High
$24.94
P/E
-2.38x
P/B
1.96x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$73.46M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.24
Operating Cash Flow
-$53M
Beta
0.96
Next Earnings
Mar 23, 2023
Ex-Dividend
N/A
Next Dividend
N/A

VERA Overview

Vera Therapeutics, Incorporated develops treatments for patients with serious immunological diseases in the U.S. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy. It is also developing MAU868, a monoclonal antibody for the treatment of BK viremia infections and is under Phase 2 clinical trial. Known as Trucode Gene Repair, Inc. until 2020, Vera Therapeutics was incorporated in 2016 and is headquartered in Brisbane, CA.

Zen Score

Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how VERA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

VERA is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
VERA is good value based on its book value relative to its share price (1.96x), compared to the US Biotechnology industry average (4.81x)
P/B vs Industry Valuation
VERA is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more VERA due diligence checks available for Premium users.

Be the first to know about important VERA news, forecast changes, insider trades & much more!

VERA News

Valuation

VERA fair value

Fair Value of VERA stock based on Discounted Cash Flow (DCF)
Price
$7.48
Fair Value
$10.26
Undervalued by
27.09%
VERA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

VERA price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-2.38x
Industry
16.1x
Market
22.37x

VERA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.96x
Industry
4.81x
VERA is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

VERA's financial health

Profit margin

Revenue
$0.0
Net Income
-$24.7M
Profit Margin
0%
VERA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$131.4M
Liabilities
$25.7M
Debt to equity
0.24
VERA's short-term assets ($124.98M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
VERA's short-term assets ($124.98M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
VERA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$18.4M
Investing
-$2.4M
Financing
$908.0k
VERA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

VERA vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
VERA$206.88M+4.91%-2.38x1.96x
ANNX$206.77M+0.61%-1.58x0.89x
DRTS$207.40M0.00%-5.66x1.96x
IMRX$207.79M-2.60%-4.12x1.89x
LRMR$208.99M-10.22%-3.53x1.88x

Vera Therapeutics Stock FAQ

What is Vera Therapeutics's quote symbol?

NASDAQ: VERA) Vera Therapeutics trades on the NASDAQ under the ticker symbol VERA. Vera Therapeutics stock quotes can also be displayed as NASDAQ: VERA.

If you're new to stock investing, here's how to buy Vera Therapeutics stock.

What is the 52 week high and low for Vera Therapeutics (NASDAQ: VERA)?

(NASDAQ: VERA) Vera Therapeutics's 52-week high was $24.94, and its 52-week low was $5.20. It is currently -70.01% from its 52-week high and 43.85% from its 52-week low.

How much is Vera Therapeutics stock worth today?

(NASDAQ: VERA) Vera Therapeutics currently has 27,657,640 outstanding shares. With Vera Therapeutics stock trading at $7.48 per share, the total value of Vera Therapeutics stock (market capitalization) is $206.88M.

Vera Therapeutics stock was originally listed at a price of $11.50 in May 14, 2021. If you had invested in Vera Therapeutics stock at $11.50, your return over the last 1 years would have been -34.96%, for an annualized return of -34.96% (not including any dividends or dividend reinvestments).

How much is Vera Therapeutics's stock price per share?

(NASDAQ: VERA) Vera Therapeutics stock price per share is $7.48 today (as of Mar 20, 2023).

What is Vera Therapeutics's Market Cap?

(NASDAQ: VERA) Vera Therapeutics's market cap is $206.88M, as of Mar 22, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Vera Therapeutics's market cap is calculated by multiplying VERA's current stock price of $7.48 by VERA's total outstanding shares of 27,657,640.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.